Trimethylamine N-Oxide and Cardiovascular Outcomes in Patients with End-stage Kidney Disease Receiving Maintenance Hemodialysis.

CONCLUSIONS: We found no evidence linking TMAO to adverse clinical outcomes in patients receiving maintenance hemodialysis with moderate to severe secondary hyperparathyroidism.
PMID: 30665924 [PubMed - as supplied by publisher]

Source: Clinical Journal of the American Society of Nephrology : CJASN - January 21, 2019 Category: Urology & Nephrology Authors: Stubbs JR, Stedman MR, Liu S, Long J, Franchetti Y, West RE, Prokopienko AJ, Mahnken JD, Chertow GM, Nolin TD Tags: Clin J Am Soc Nephrol Source Type: research